BBS Council
- Hans Ulrich Burger, F. Hoffmann-La Roche Ltd (President)
- Fred Sorenson, Xcenda (Treasurer)
- Marisa Bacchi, Actelion Pharmaceuticals Ltd
- Marco Cattaneo, University of Basel
- Lilla Di Scala, Actelion Pharmaceuticals Ltd
- Achim Guettner, Novartis Pharma AG
- Dominik Heinzmann, F. Hoffmann-La Roche Ltd
- Roland Marion-Gallois, Celgene
- Giusi Moffa, University of Basel
- Amanda Ross, Swiss Tropical and Public Health Institute
- Kaspar Rufibach, F. Hoffmann-La Roche Ltd
- Juliane Schaefer, F. Hoffmann-La Roche Ltd
- Marc Vandemeulebroecke, Novartis Pharma AG
- Pierre Verweij, Idorsia Pharmaceuticals Ltd
- Simon Wandel, Novartis Pharma AG
- Marcel Wolbers, F. Hoffmann-La Roche Ltd
BBS Purpose
The Basel Biometric Section is part of the ROeS, the Austrian Swiss Region of the International Biometric Society (IBS). BBS is an independent, non-profit organization which provides a forum for discussions of how to apply statistical methods in biological and medical science.
Sorry, the comment form is closed at this time.